NHS Guidelines for Mounjaro: How Access and Prescribing Work

Prescribing guidelines for medicines like Mounjaro exist to help clinicians decide when a treatment is appropriate for a given patient. For weight-management medicines, these guidelines typically consider factors such as body mass index (BMI), the presence of weight-related health conditions, and whether other approaches have already been tried — though the specifics vary by country and healthcare system.

Guidelines in the UK context

In England, guidance from NICE (the National Institute for Health and Care Excellence) sets out the criteria under which Mounjaro may be prescribed within NHS-commissioned services. This guidance is intended for healthcare professionals and informs commissioning decisions. Separately, Mounjaro can also be prescribed through private routes, where individual prescribers apply clinical judgement alongside the medicine's licensed indication. For a factual overview of how NHS access pathways are structured, access to Mounjaro through NHS routes covers the key points in more detail.

Guidelines for Wegovy (semaglutide)

Wegovy follows a similar pattern. National-level guidance shapes NHS commissioning, while private prescribers work within the medicine's licensed criteria. If you want to understand how the prescribing picture compares, NHS guidelines for Wegovy provides a useful parallel overview.

What this means if you are already prescribed

If you have already been prescribed Mounjaro, your prescriber has already determined that it is appropriate for you under the relevant guidelines — whether NHS or private. The guidelines exist to support that clinical decision, not to limit what you can do on your journey once you are underway. For a broader look at how Mounjaro is used within NHS weight-management programmes, that page explores the wider context.

It is worth noting that guidelines can be updated as new evidence emerges. Your prescriber or doctor is the right person to ask about how current guidance applies to your individual situation.

Once you are prescribed Mounjaro, the day-to-day work of staying consistent — logging each dose, tracking how you feel, and monitoring your progress — is where a companion app can make a real difference. GLP Trackr's dose logging feature lets you record every injection: the date, time, and dose strength, all in one place. This means you always have an accurate record to refer back to, and one you can bring to your prescriber at your next appointment.

Beyond dose logging, GLP Trackr's side-effect tracker lets you note symptoms like nausea or fatigue as they happen and watch for patterns over time. Many people find it genuinely useful to arrive at a prescriber appointment with a clear picture of what they have experienced, rather than trying to recall it from memory. The app's doctor report feature pulls your logged data together into a summary designed for exactly that kind of conversation.

For broader reading on the cost and access landscape, understanding Mounjaro costs and access covers topics many people on this journey find relevant.

GLP Trackr does not sell, supply, or source Mounjaro or any other medicine. If you have questions about how to access a prescription, or about how guidelines apply to you, your prescriber or doctor — and a registered pharmacy in your country — are the right places to start.

Important: Any questions about whether Mounjaro is suitable for you, or about changes to your treatment, should always be discussed with your prescriber. GLP Trackr supports your journey — it is not a substitute for clinical guidance.

Ready to keep your journey organised in one place? Download GLP Trackr on the App Store or Google Play and explore it free for your first seven days.